DEXCOM INC — Director's Dealing 2013

Sep 10, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2013-09-09

Reporting Person: Balo Andrew K (SVP, Regulatory and Clinical)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-09	Common Stock	D	6200.0	$26.8894	Disposed	138565	Direct

Footnotes

F1: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.

F2: Included in this number are 84,203 unvested restricted stock units, 50,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016, 26,875 of which were granted on March 8, 2012 and shall vest through March 8, 2015, and 7,328 of which were granted on March 8, 2011 and shall vest through March 8, 2014.